StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.92+0.18 (+23.51%)

Close on Nov 18, 2026Market cap $42.43MP/E –Yield –

OS Therapies net income

Net income is the profit left for shareholders after every expense, interest and tax.

OS Therapies's net income for the twelve months ending Jun 30, 2026 was -$39.37M. For fiscal 2025 it was -$28.75M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$28.75M–
FY2024Dec 31, 2024-$8.88M–
FY2023Dec 31, 2023-$7.79M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.63M–
Q1 FY2026Mar 31, 2026-$10.40M–
Q4 FY2025Dec 31, 2025-$13.46M–
Q3 FY2025Sep 30, 2025-$6.88M–
Q2 FY2025Jun 30, 2025-$4.54M–
Q1 FY2025Mar 31, 2025-$3.88M–
Q4 FY2024Dec 31, 2024-$2.99M–
Q3 FY2024Sep 30, 2024-$2.88M–
Q2 FY2024Jun 30, 2024-$1.56M–
Q1 FY2024Mar 31, 2024-$1.46M–
Q4 FY2023Dec 31, 2023-$1.46M–
Q3 FY2023Sep 30, 2023-$1.97M–
Q2 FY2023Jun 30, 2023-$2.51M–
Q1 FY2023Mar 31, 2023-$1.85M–

More OS Therapies figures

See a number that looks wrong?